Antigen‐specific suppression of established arthritis in mice by dendritic cells deficient in NF‐κB

Abstract

BAY 11-7082-treated DCs induce antigen-specific immune suppression in this model of inflammatory arthritis, even after full clinical expression of the disease. Such DCs have potential as antigen-specific therapy for autoimmune inflammatory arthritis, including RA.